TR200100338T2 - Ödem tedavisinde kullanılan TNF-türevleri peptitler. - Google Patents
Ödem tedavisinde kullanılan TNF-türevleri peptitler.Info
- Publication number
- TR200100338T2 TR200100338T2 TR2001/00338T TR200100338T TR200100338T2 TR 200100338 T2 TR200100338 T2 TR 200100338T2 TR 2001/00338 T TR2001/00338 T TR 2001/00338T TR 200100338 T TR200100338 T TR 200100338T TR 200100338 T2 TR200100338 T2 TR 200100338T2
- Authority
- TR
- Turkey
- Prior art keywords
- tnf
- edema
- alpha
- treatment
- present
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 206010030113 Oedema Diseases 0.000 title abstract 3
- GJLXVWOMRRWCIB-MERZOTPQSA-N (2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanamide Chemical compound C([C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)C1=CC=C(O)C=C1 GJLXVWOMRRWCIB-MERZOTPQSA-N 0.000 abstract 1
- 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 206010037423 Pulmonary oedema Diseases 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 102000057041 human TNF Human genes 0.000 abstract 1
- 208000005333 pulmonary edema Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/525—Tumour necrosis factor [TNF]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Pulmonology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Mevcut bulus, tümör nekrosit faktör-alfanin (TNF-alfa) bir spesifik alanindan türetilen peptitlerin ödem tedavisinde etkin bir sekilde kullanimina dayanmaktadir. Daha spesifik olarak, mevcut bulus Ser100 den Glu 116 a insan TNF-alfa'sinin bölgesinden türetilen peptitlerin, pulmonar ödemin tedavisinde kullanimina iliskindir. Hatta mevcut bulus, CGQRETPEGAEAKPWYC amino asit sekansi içeren sirkülarize peptitlerinin ödem resorpsyonunu azaltmada çok etkin bulunmaktadir.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98870180 | 1998-08-14 | ||
EP98870198 | 1998-09-18 | ||
EP98870222 | 1998-10-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200100338T2 true TR200100338T2 (tr) | 2001-12-21 |
Family
ID=27239778
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2001/00338T TR200100338T2 (tr) | 1998-08-14 | 1999-08-10 | Ödem tedavisinde kullanılan TNF-türevleri peptitler. |
Country Status (21)
Country | Link |
---|---|
US (2) | US20030105021A1 (tr) |
EP (3) | EP1264599B1 (tr) |
JP (1) | JP4542266B2 (tr) |
CN (1) | CN1181886C (tr) |
AT (2) | ATE374039T1 (tr) |
AU (1) | AU764992B2 (tr) |
BR (1) | BR9912899A (tr) |
CA (1) | CA2334941C (tr) |
CZ (1) | CZ302862B6 (tr) |
DE (2) | DE69937206T2 (tr) |
DK (1) | DK1264599T3 (tr) |
ES (1) | ES2296872T3 (tr) |
HK (1) | HK1051805A1 (tr) |
HU (1) | HU227661B1 (tr) |
IL (2) | IL141064A0 (tr) |
NZ (1) | NZ509604A (tr) |
PL (1) | PL203706B1 (tr) |
PT (1) | PT1264599E (tr) |
TR (1) | TR200100338T2 (tr) |
WO (1) | WO2000009149A1 (tr) |
ZA (1) | ZA200100656B (tr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1264599B1 (en) | 1998-08-14 | 2007-09-26 | Rudolf Lucas | TNF-derived peptides for use in treating oedema |
AU2005268755B2 (en) * | 2004-08-06 | 2011-04-07 | Takeda Gmbh | Composition comprising a pulmonary surfactant and a TNF-derived peptide |
EP2009023A1 (en) * | 2007-06-04 | 2008-12-31 | Rentschler Beteiligungs GmbH | Novel peptides and their use for the treatment of edema |
AT506151B1 (de) | 2007-12-12 | 2010-01-15 | Apeptico Forschung Und Entwick | Fusionsprotein |
AT506150B1 (de) | 2007-12-12 | 2010-01-15 | Apeptico Forschung Und Entwick | Zyklisches und cystein-freies peptid |
AT507953B1 (de) * | 2009-03-05 | 2011-02-15 | Apeptico Forschung & Entwicklung Gmbh | Verfahren zur vermeidung und zur behandlung einer hyperpermeabilität |
AT509267A1 (de) | 2010-01-14 | 2011-07-15 | Apeptico Forschung & Entwicklung Gmbh | Organische verbindungen zur regulierung von vektoriellen ionenkanälen |
PL2397151T3 (pl) * | 2010-06-21 | 2015-10-30 | Apeptico Forschung & Entwicklung Gmbh | Leczenie powikłań naczyniowych cukrzycy |
AT510585B1 (de) * | 2010-11-18 | 2012-05-15 | Apeptico Forschung & Entwicklung Gmbh | Zusammensetzung umfassend ein peptid und ein hemmstoff der viralen neuraminidase |
US11161881B2 (en) * | 2010-11-18 | 2021-11-02 | Apeptico Forschung Und Entwicklung Gmbh | Composition comprising a peptide and an inhibitor of viral neuraminidase |
EP2679239A1 (de) * | 2012-06-28 | 2014-01-01 | Apeptico Forschung und Entwicklung GmbH | Pharmazeutische Zusammensetzung zur Behandlung der durch Sauerstoffarmut und verringerten Luftdruck vermittelten pulmonalen Form der Höhenkrankheit |
US20160143266A1 (en) * | 2013-04-23 | 2016-05-26 | Apeptico Forschung Und Entwicklung Gmbh | Pharmaceutical Composition Comprising a Cyclic peptide of formula X1-GQRETPEGAEAKPWY-X2 and use for extracorporeal lung treatment |
WO2015140125A2 (en) | 2014-03-18 | 2015-09-24 | Apeptico Forschung Und Entwicklung Gmbh | Dry-powder peptide medicament |
CN110613838A (zh) * | 2018-06-19 | 2019-12-27 | 姜石松 | 增强细胞通透性的多肽及其应用 |
ES2938574T3 (es) | 2020-05-08 | 2023-04-12 | Apeptico Forschung & Entwicklung Gmbh | Péptido para la prevención o el tratamiento de la COVID-19 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE384179C (de) * | 1921-04-07 | 1923-10-27 | Ludwig Weil Dr | Laufrad fuer Kreiselpumpen und -geblaese |
DE3841759A1 (de) | 1988-12-12 | 1990-06-13 | Basf Ag | Neue tnf-peptide |
US5891679A (en) | 1993-02-03 | 1999-04-06 | N.V. Innogenetics S.A. | TNF-alpha muteins and a process for preparing them |
EP1264599B1 (en) | 1998-08-14 | 2007-09-26 | Rudolf Lucas | TNF-derived peptides for use in treating oedema |
-
1999
- 1999-08-10 EP EP02077256A patent/EP1264599B1/en not_active Expired - Lifetime
- 1999-08-10 WO PCT/EP1999/005806 patent/WO2000009149A1/en not_active Application Discontinuation
- 1999-08-10 AT AT02077256T patent/ATE374039T1/de active
- 1999-08-10 IL IL14106499A patent/IL141064A0/xx unknown
- 1999-08-10 EP EP99942835A patent/EP1105152A1/en not_active Withdrawn
- 1999-08-10 CZ CZ20010538A patent/CZ302862B6/cs not_active IP Right Cessation
- 1999-08-10 AU AU56209/99A patent/AU764992B2/en not_active Ceased
- 1999-08-10 PT PT02077256T patent/PT1264599E/pt unknown
- 1999-08-10 CA CA2334941A patent/CA2334941C/en not_active Expired - Lifetime
- 1999-08-10 ES ES02077256T patent/ES2296872T3/es not_active Expired - Lifetime
- 1999-08-10 JP JP2000564651A patent/JP4542266B2/ja not_active Expired - Lifetime
- 1999-08-10 DE DE69937206T patent/DE69937206T2/de not_active Expired - Lifetime
- 1999-08-10 BR BR9912899-3A patent/BR9912899A/pt active Search and Examination
- 1999-08-10 AT AT02077274T patent/ATE395072T1/de active
- 1999-08-10 TR TR2001/00338T patent/TR200100338T2/tr unknown
- 1999-08-10 HU HU0103117A patent/HU227661B1/hu not_active IP Right Cessation
- 1999-08-10 CN CNB998096555A patent/CN1181886C/zh not_active Expired - Lifetime
- 1999-08-10 DK DK02077256T patent/DK1264599T3/da active
- 1999-08-10 EP EP02077274A patent/EP1247531B1/en not_active Expired - Lifetime
- 1999-08-10 DE DE69938743T patent/DE69938743D1/de not_active Expired - Lifetime
- 1999-08-10 NZ NZ509604A patent/NZ509604A/en not_active IP Right Cessation
- 1999-08-10 PL PL345997A patent/PL203706B1/pl unknown
-
2001
- 2001-01-23 ZA ZA2001/00656A patent/ZA200100656B/en unknown
- 2001-01-24 IL IL141064A patent/IL141064A/en not_active IP Right Cessation
- 2001-02-09 US US09/779,703 patent/US20030105021A1/en not_active Abandoned
-
2002
- 2002-06-06 US US10/162,553 patent/US7258861B2/en not_active Expired - Lifetime
-
2003
- 2003-04-30 HK HK03103102A patent/HK1051805A1/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200100338T2 (tr) | Ödem tedavisinde kullanılan TNF-türevleri peptitler. | |
DK1337157T3 (da) | Proteinhydrolysater | |
CY1107668T1 (el) | Χρηση αμινοξικων αντισπασμωδικων για τη θεραπευτικη αγωγη του πονου | |
IL161591A (en) | Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells | |
EA200000933A1 (ru) | Пептидные композиции и препараты и их применение | |
HUP0000492A1 (hu) | N-(Aril/heteroaril-acetil)-aminosav-észterek, azokat tartalmazó gyógyászati készítmények, valamint módszerek béta-amiloid fehérje képződése és felszabadulása gátlására e vegyületek felhasználásával | |
DE60331546D1 (de) | Verwendung von aspartic proteasen in den bereichen kosmetik und behandlung | |
BR0012418A (pt) | Derivados de peptìdeo cìclicos como inibidores de integrina alfavbeta6 | |
ATE443076T1 (de) | Von protease typ ii spaltbares peptid | |
ATE427320T1 (de) | Behandlung von infektionen verursacht von mikroorganismen | |
ATE198987T1 (de) | Behandlung von tropikalischer spastischer paresis mit peptide t | |
DE69330268D1 (de) | Hämoregulierende peptide | |
ATE536366T1 (de) | Peptidinhibitoren von hk2 und deren anwendung | |
DE60104695D1 (de) | Zusammensetzungen aus aminosäuren zur behandlung von herzinsuffizienz | |
ATE218334T1 (de) | Verwendung von gabapentin in der behandlung vonangst - und panikstörungen | |
FI20012082A0 (fi) | Biologisesti aktiiviset peptidit hermovauroiden korjaamiseksi | |
EP1557466A4 (en) | TUMOR ANTIGEN PROTEIN AND USE THEREOF | |
SE9901773D0 (sv) | Förebyggande av karies i tänderna | |
DE602004003508D1 (de) | Aus pflanzen gewonnene peptide mit wasserreinigender und antimikrobieller wirkung | |
DE60008749D1 (de) | Therapeutische peptide aus untersequenzen von bpi | |
DE60143025D1 (de) | Zusammensetzung zur behandlung von periodontalen erkrankungen |